Yes it’s good timing for the SPP you would think...
Its an excellent advancement on the current PFS and also this is in a very late stage population... 3.4 to 5.5 an increase of 2.1 or roughly a 60% increase in 3.4.
thats a meaningful extension for sure.
if this was administered to a more recently diagnosed population already in better health you would expect that these figures would be even more ‘robust’.
- Forums
- ASX - By Stock
- KZA
- Ann: Cantrixil last patient visit
Ann: Cantrixil last patient visit, page-6
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)